Case/Non-Case Analysis of the FDA Adverse Events Reporting System (FAERS) Unveils Higher Reporting Odds of Photosensitivity and Esophageal Symptoms for Sarecycline Compared to Other Tetracyclines - Supplemental Data

Name: Case/Non-Case Analysis of the FDA Adverse Events Reporting System (FAERS) Unveils Higher Reporting Odds of Photosensitivity and Esophageal Symptoms for Sarecycline Compared to Other Tetracyclines - Supplemental Data
Creator: Patrick Jedlowski
Published: 2022-02-16T12:11:39.692Z
Keywords: Dermatology, Tetracycline

Jedlowski, Patrick

doi:10.17632/322n8jrkxs.1

Case/Non-Case Analysis of the FDA Adverse Events Reporting System (FAERS) Unveils Higher Reporting Odds of Photosensitivity and Esophageal Symptoms for Sarecycline Compared to Other Tetracyclines - Supplemental Data

Published: 16 February 2022| Version 1 | DOI: 10.17632/322n8jrkxs.1

Contributor:

Patrick Jedlowski

Description

Supplemental data to accompany publication in JAAD

Files

Institutions

University of Arizona College of Medicine

Case/Non-Case Analysis of the FDA Adverse Events Reporting System (FAERS) Unveils Higher Reporting Odds of Photosensitivity and Esophageal Symptoms for Sarecycline Compared to Other Tetracyclines - Supplemental Data

Description

Files

Institutions

Categories

Licence